Rare diseases
Investigational molecules
Locations
Back to Czechia46 clinical trials in Slany, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
CzechiaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
CzechiaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
CzechiaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
CzechiaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
CzechiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
CzechiaStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
CzechiaTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
CzechiaStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
CzechiaStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
CzechiaPhase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on cardiovascular diseases and treatments, including trials for stroke prevention and heart conditions. Research encompasses new therapies for patients with atrial fibrillation and acute coronary syndrome.
Multiple trials evaluating novel anticoagulants and comparing their effectiveness to existing treatments.
Comprehensive research into inflammatory bowel conditions, with particular focus on ulcerative colitis and Crohn's disease. Studies evaluate new therapeutic approaches for moderate to severe cases.
Several trials testing innovative biological therapies and maintenance treatments for gastroenterological conditions.
Advanced research targeting metabolic conditions, including hypertriglyceridemia and cholesterol management. Studies focus on developing treatments for various lipid disorders.
Trials evaluating new medications for improving lipid profiles and reducing cardiovascular risk factors.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
